Cytori’s Precise trial results shows stem & regenerative cells from body fat improves heart function
The first clinical trial of adipose (fat) tissue-derived stem and regenerative cells (ADRCs) for the treatment of no-option chronic heart disease patients showed that the procedure was safe and feasible.
Read more on PharmaBiz
Lithera Reports Positive Clinical Study Results From a Second Phase IIa Trial for LIPO-102, a Novel Treatment for …
SAN DIEGO — Lithera, Inc. today announced positive results from a Phase IIa clinical study of LIPO-102, its novel injectable combination of salmeterol xinafoate and fluticasone propionate for selective, non-ablative fat reduction.
Read more on GlobeNewswire via Yahoo! Finance
Conclusion The use of lidocaine in the tumescent solution for subcutaneous fat infiltration significantly increases postoperative anemia
compared with the results obtained when epinephrine infiltration alone is used.
Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00266-009-9343-yAuthors
Sergio Llanos, Llanos Subercaseaux 2959 Depto 1001 San Miguel ChileBruno Dagnino, Plastic, Reconstructive, and Burn Unit, Hospital Militar de Santiago Santiago ChileDaniel Ponce, Hospital Parroquial de San Bernardo Santiago ChileSebastián Bonacic, Hospital General Yague de Burgos Burgos SpainLindaura Navarrete, Hospital Parroquial de San Bernardo Santiago ChileSandra Navarrete, Hospital Parroquial de San Bernardo Santiago ChileGünther Mangelsdorff, Pontificia Univer…
Source: MedWorm: Liposuction